Amoy Diagnostics (300685.SZ) Earnings Analysis

Amoy Diagnostics (300685.SZ) next reports earnings on 2026-07-31, consensus EPS 0.21 CNY. Last quarter (2026-04-27) it missed with EPS 0.215 CNY vs 0.25 CNY est (-14%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E 19.11.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 300685.SZ next report earnings?

Next earnings date2026-07-31
Consensus EPS estimate0.21 CNY
Revenue estimate0.35B

300685.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-270.215 CNY0.25 CNY-14%Miss
2026-03-120.288 CNY0.269 CNY+7.1%Beat
2025-10-240.189 CNY0.26 CNY-27.3%Miss
2025-04-210.07 CNY0.23 CNY-69.6%Miss
2025-03-310.23 CNYn/an/an/a
2024-10-210.21 CNY0.18 CNY+16.7%Beat
2024-07-290.2 CNY0.21 CNY-4.8%Miss

Beat rate: 2/6 (33%) over reported quarters with consensus data.

300685.SZ valuation and analyst view

Trailing P/E19.11
Trailing EPS0.91337 CNY
Price / book3.26
Dividend yield2.62%
Market cap6.84B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Amoy Diagnostics (300685.SZ)'s next earnings date?

Amoy Diagnostics is next scheduled to report on 2026-07-31, with a consensus EPS estimate of 0.21 CNY and revenue estimate of 0.35B.

Did 300685.SZ beat earnings last quarter?

In its 2026-04-27 report, 300685.SZ posted EPS of 0.215 CNY versus a 0.25 CNY estimate — a miss of 14%.

What is 300685.SZ's earnings track record?

Over the last 6 reported quarters with consensus data, 300685.SZ beat estimates 2 times (33%).

What is 300685.SZ's current P/E ratio and EPS?

300685.SZ trades at a trailing P/E of 19.11 on trailing EPS of 0.9133733445280655 CNY.

What do analysts rate 300685.SZ?

300685.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.